Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
77,737,863
-
Share change
-
-844,839
-
Total reported value
-
$554,279,560
-
Put/Call ratio
-
515%
-
Price per share
-
$7.13
-
Number of holders
-
169
-
Value change
-
-$160,875,591
-
Number of buys
-
89
-
Number of sells
-
123
Institutional Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) as of Q1 2020
As of 31 Mar 2020,
PORTOLA PHARMACEUTICALS INC - COM (PTLA) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,737,863 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Temasek Holdings (Private) Ltd, Jackson Square Partners, LLC, STATE STREET CORP, CADIAN CAPITAL MANAGEMENT, LP, Rock Springs Capital Management LP, and FIERA CAPITAL CORP.
This page lists
169
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.